These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6291869)

  • 21. Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics.
    Hooton TM; Blair AD; Turck M; Counts GW
    Antimicrob Agents Chemother; 1984 Oct; 26(4):535-8. PubMed ID: 6517544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro comparison of aminoglycoside activities and their synergistic action with piperacillin.
    Hoogkamp-Korstanje JA
    Infection; 1985; 13(1):39-42. PubMed ID: 3988352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacteriostatic and bactericidal effect of cefotaxime combinations on Staphylococcus aureus assessed by FIC and FBC-index determination].
    Reynaud A; Drugeon HB; Courtieu AL
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):545-9. PubMed ID: 3911153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
    Vrbová E; Uxová M; Výmola F
    Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    Machka K; Dietz R
    Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
    Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
    J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO; Izard D; Leclerc H
    Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative effects of netilmicin and 4 other aminoglycosides on 1028 bacterial strains isolated in a hospital milieu].
    Reynaud A; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 Mar; 33(3):189-94. PubMed ID: 3892446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance of Listeria monocytogenes to cefotaxime and ceftriaxone combined with an aminoside].
    Borderon E; Borderon JC; Feron JF; Thieffry JC; Tescher M; Farid IA
    Pathol Biol (Paris); 1987 May; 35(5):568-71. PubMed ID: 3112709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefotaxime: microbiology, pharmacology, and clinical use.
    Dudley MN; Barriere SL
    Clin Pharm; 1982; 1(2):114-24. PubMed ID: 6309465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial activity of netilmicin in combination with other antibiotics. Comparison with other aminoglycosides (author's transl)].
    Cluzel M; Sirot J; Chanal M; Sirot D; Roussanne MC
    Pathol Biol (Paris); 1982 Jun; 30(6):376-9. PubMed ID: 7050845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.